Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced an evolution of its corporate positioning to ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

Systematic review finds convection-enhanced delivery in pediatric patients is linked mainly to low-grade adverse events, with no Grade 4 or 5 toxicity, supporting safer investigational CNS therapy ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to cancer cells and not normal cells, potentially allowing clinicians to ...

Controlled release drug delivery systems have transformed the pharmaceutical landscape by offering sustained therapeutic action and improved patient compliance. These ...

A dissolvable drug capsule uses radiofrequency signals to ensure that people are taking their medication on schedule ...

A project that began as a Gates Foundation-funded effort to expand contraceptive options, particularly in developing nations, has led to the development of a new method to deliver certain drugs in ...